USANA Health Sciences, Inc. (NYSE:USNA) to Post Q2 2024 Earnings of $0.68 Per Share, DA Davidson Forecasts

USANA Health Sciences, Inc. (NYSE:USNA) – Stock analysts at DA Davidson issued their Q2 2024 earnings per share (EPS) estimates for shares of USANA Health Sciences in a report issued on Tuesday, May 7th. DA Davidson analyst L. Weiser forecasts that the company will earn $0.68 per share for the quarter. DA Davidson has a “Neutral” rating and a $46.00 price objective on the stock. The consensus estimate for USANA Health Sciences’ current full-year earnings is $2.75 per share.

Separately, StockNews.com upgraded shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research report on Friday, January 12th.

USANA Health Sciences Price Performance

Shares of USNA stock opened at $45.07 on Wednesday. The stock has a market capitalization of $865.34 million, a PE ratio of 14.04, a PEG ratio of 1.38 and a beta of 0.94. The business’s 50 day simple moving average is $46.42 and its 200 day simple moving average is $48.05. USANA Health Sciences has a one year low of $41.45 and a one year high of $69.60.

USANA Health Sciences (NYSE:USNA) last announced its earnings results on Tuesday, February 6th. The company reported $0.87 EPS for the quarter, topping the consensus estimate of $0.52 by $0.35. USANA Health Sciences had a return on equity of 12.80% and a net margin of 6.88%. The firm had revenue of $221.08 million for the quarter, compared to the consensus estimate of $206.70 million.

Institutional Trading of USANA Health Sciences

Several hedge funds have recently bought and sold shares of USNA. Hsbc Holdings PLC purchased a new stake in shares of USANA Health Sciences during the 3rd quarter valued at $570,000. Pacer Advisors Inc. increased its holdings in USANA Health Sciences by 75.7% in the 4th quarter. Pacer Advisors Inc. now owns 337,371 shares of the company’s stock worth $18,083,000 after acquiring an additional 145,373 shares during the last quarter. Jacobs Levy Equity Management Inc. raised its stake in USANA Health Sciences by 2.4% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 90,659 shares of the company’s stock valued at $5,314,000 after acquiring an additional 2,168 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in USANA Health Sciences by 3.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 213,887 shares of the company’s stock valued at $12,536,000 after purchasing an additional 8,084 shares during the last quarter. Finally, Exchange Traded Concepts LLC boosted its position in USANA Health Sciences by 7.6% during the fourth quarter. Exchange Traded Concepts LLC now owns 16,534 shares of the company’s stock worth $886,000 after purchasing an additional 1,162 shares during the period. Institutional investors and hedge funds own 54.25% of the company’s stock.

Insiders Place Their Bets

In other USANA Health Sciences news, insider Daniel A. Macuga sold 3,791 shares of USANA Health Sciences stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $47.14, for a total value of $178,707.74. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, insider Daniel A. Macuga sold 3,791 shares of the firm’s stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $47.14, for a total value of $178,707.74. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Robert A. Sinnott sold 3,945 shares of the company’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $46.55, for a total value of $183,639.75. The disclosure for this sale can be found here. In the last ninety days, insiders sold 34,286 shares of company stock worth $1,634,010. Company insiders own 0.33% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.